-+ 0.00%
-+ 0.00%
-+ 0.00%
20/20 BioLabs to host investor webinar on FDA advisory panel vote, OneTest franchise model
Share
Listen to the news
20/20 BioLabs to host investor webinar on FDA advisory panel vote, OneTest franchise model
  • 20/20 BioLabs will host an investor webinar on Oct. 7, 2026 at 12:00 p.m. ET.
  • Management plans to discuss the Sept. 23, 2026 FDA advisory committee vote on GRAIL’s Galleri test, read-through for MCED regulation.
  • Discussion will also cover the OneTest franchise model, early lab interest, state-backed firefighter cancer screening initiatives, followed by Q&A.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 20/20 Biolabs Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290831PRIMZONEFULLFEED9835519) on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending